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INTRODUCTION
Significant aortic stenosis carries a poor prognosis when
associated with congestive heart failure (1, 2), with such pa-
tients having an average life expectancy of approximately two
years if not treated (3). Although aortic valve replacement
represents the only effective treatment, little is known regard-
ing long-term survival and changes in systolic function fol-
lowing surgery after the occurrence of a severe left ventricular
dysfunction. The present study examined the surgical out-
comes, post-operative left ventricular changes, and the pre-
operative predictors of postoperative cardiac death in the
patients with significant aortic stenosis and severe left ven-
tricular dysfunction who underwent aortic valve replacement.
MATERIALS AND METHODS
Study populations
The present study included all patients who underwent aor-
tic valve replacement for significant aortic stenosis and severe
left ventricular (LV) dysfunction between January 1990 and
July 2007 at Asan Medical Center. Significant aortic stenosis
was defined as an aortic valve area less than 1 cm2, and severe
LV dysfunction as an LV ejection fraction (EF) less than 35%.
During the study period, 1,460 patients underwent aortic
valve replacement and among these patients, single aortic
valve replacement was performed in 688 patients.
Patients were excluded from the study if they were <18 yr
old, had double or triple valve surgery, or had more than mod-
erate (>3+/4) aortic or mitral regurgitation according to ec-
hocardiography. Patients who underwent concomitant coro-
nary artery bypass surgery or re-operation were included in
the present study. The present study was approved by our
Institutional Review Board (IRB) of Asan Medical Center,
Seoul, Korea. The requirement for informed patient consent
was waived by the IRB owing to the retrospective nature of
the study.
Follow-up information was obtained from the medical re-
cords. If the patient had not been seen in clinic within the
previous six months, follow-up information was obtained
from telephone conversations between the patients and one
of the investigators. When it was impossible to contact with
patients, we have referred to the database of the National He-
alth Insurance Corporation to know whether the patients have
been dead or not. The mean follow up duration was 58.6 mo-
nths (range, 0.9-189.1 months).
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Surgical Outcomes and Post-Operative Changes in Patients with
Significant Aortic Stenosis and Severe Left Ventricle Dysfunction
Little is known regarding long-term survival and changes in systolic function follow-
ing surgery after the occurrence of a severe left ventricular (LV) dysfunction in pati-
ents with severe aortic stenosis. Inclusion criteria were an aortic valve area less than
1 cm
2 and an LV ejection fraction (EF) less than 35%. Between January 1990 and
July 2007, 41 (male: 30) patients were identified. The pre-operative mean EF and
mean aortic valve area were 26.7±6.1% and 0.54±0.2 cm
2, respectively. Concomi-
tant coronary artery bypass surgery was performed in 8 patients (19.6%). Immedi-
ate post-operative echocardiogram showed to be much improved in LV EF (27.2±
5.5 vs. 37.4±11.3, P<0.001), LV mass index (244.2±75.3 vs. 217.5±71.6, P=
0.006), and diastolic LV internal diameter (62.5±9.3 vs. 55.8±9.6, P<0.001). Post-
operative LV changes were mostly complete by 6 months, and were maintained
thereafter. There was one in-hospital mortality (2.4%) and 12 late deaths including
one patient diagnosed with malignancy in whom LV function was normal. Multivari-
ate analysis showed pre-operative atrial fibrillation and NYHA FC IV to be significant
risk factors for cardiac-related death. Aortic valve replacement in patients with sig-
nificant aortic stenosis and severe LV dysfunction showed acceptable surgical out-
comes. Moreover, LV function improved significantly in many patients.
Key Words : Aortic Valve Stenosis; Ventricular Dysfunction, Left; Heart Valve Prosthesis
Received : 23 July 2008
Accepted : 25 October 2008Aortic Stenosis with Left Ventricle Dysfunction 813
Echocardiographic methods
Comprehensive two-dimensional and Doppler transtho-
racic echocardiography was performed in all patients pre-
operatively. The echocardiographic examinations were per-
formed by one experienced observer. The left ventricular mass
(g) was calculated as 1.04 ([LVID+PWT+IVST]3-LVID3)×
0.8+0.6, where LVID is the internal dimension, PWT is the
posterior wall thickness, and IVST is the interventricular sep-
tal thickness. Left ventricular ejection fraction (%) was cal-
culated as stroke volume in percent of end-diastolic volume.
Aortic valve hemodynamic data were assessed using standard
methods, and the aortic valve area (AVA) was calculated with
the continuity equation: AVA= (LVOT area X LVOT TVI)/
aortic TVI, where LVOT is LV outflow tract and TVI is time-
velocity integral. Immediate postoperative study was under-
taken using echocardiography at 1 week after surgery. Echoc-
ardiograph examinations were possible at more than 6 months
postoperatively in 31 patients, and the mean interval from
surgery to the final postoperative echocardiography was 26.0
(0.1-130.2) months.
Surgical procedure
All patients underwent aortic valve replacement using me-
chanical or tissue valves. Bentall’s operation was performed
in one patient with a mechanical valved-conduit. The patient
who underwent Bentall’s operation was diagnosed with infec-
tive endocarditis and underlying aortic stenosis. Destruction
was so severe and involved aortic annulus and aortic wall, so
extensive debridement was required and then aortic root re-
placement was necessary. The type and size of the aortic pros-
thetic valve, concomitant coronary artery bypass graft surgery
and the aortic cross clamp and cardiopulmonary bypass dura-
tion were recorded. 
Statistical analysis
Data are expressed as mean±standard deviation for con-
tinuous variables, and as numbers with percentage for cate-
gorical variables. Paired and unpaired Student’s t tests were
performed to determine intragroup and intergroup differences
between mean values for continuous variables, as appropri-
ate. Changes in post-operative echocardiographic findings
were analyzed using repeated measures ANOVA. The overall
survival was estimated using the Kaplan-Meier method. Risk
factor analysis for cardiac-related death was performed using
Cox-regression analysis. A P value <0.05 was considered to
indicate a significant difference. SPSS software 14.0 (Korean
version; SPSS, Inc, Chicago, IL, U.S.A.) was used for statis-
tical analysis.
RESULTS
Forty-one patients were identified, and the baseline clini-
cal data are summarized in Table 1. The number of operation
per year was described (Fig. 1). The pre-operative mean EF
and mean aortic valve area were 26.7±6.1% and 0.54±
0.2 cm2, respectively. Mean transvalvular gradient was 48.2
±17.4 mmHg. Pulmonary artery hypertension defined as
estimated right ventricular systolic pressure more than 50
mmHg was present in 16 patients (45.7%). Pre-operative
electrocardiogram showed to be sinus rhythm in 31 patients
and atrial fibrillation in 10 patients (24.4%). All patients
showed significant symptoms such as dyspnea (n=38), chest
discomfort or pain (n=14), and syncope (n=2). Aortic valve
pathology was degenerative change (n=26), rheumatic cause
(n=1), bicuspid aortic valve (n=13), or infective endocarditis
(n=2). All patients underwent either simple aortic valve re-
placement (n=40) or Bentall’s operation (n=1) (mechanical:
23, tissue: 18). The mean valve size was 22.4±2.2 (19-29)
mm. Five patients received 19 mm valves (2 St. Jude Medi-
cal bileaflet mechanical valves, 1 Hancock II valve, 1 Magna
*Values represent mean±SD (range); 
� Values in parentheses are per-
centages.
Characteristics Findings
Age (yr)* 61.0±12.2 (31-79)
Sex (M:F) 30:11
Body surface area (m
2)* 1.65±0.2 (1.15-2.55)
NYHA class (n)
II 17
III 16
IV 8
Coronary artery disease (No.) 10
Creatinine (Cr) level* 1.12±1.1
Comorbidities, No. of patients (%)
�
Systemic hypertension 11 (26.8)
Diabetes mellitus 11 (26.8)
Peripheral vascular disease 2 (4.9)
Chronic renal failure (Cr >1.4 g/dL) 5 (12.2)
Chronic obstructive lung disease 5 (12.2)
Table 1. Pre-operative clinical data
Fig. 1. The number of operation per year.
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valve, and 1 Carpentier-Edwards pericardial bioprostheses),
14 patients received 21 mm valves (6 St. Jude Medical bile-
aflet mechanical valves, 1 St. Jude Medical regent valves, 2
MIRA valves, 4 Carpentier-Edwards pericardial bioprosthe-
ses, and 1 Biocor valve), 13 patients received 23 mm valves
(5 St. Jude Medical valves, 5 Carpentier-Edwards biopros-
theses, 1 Hancock valve, 1 MIRA valve, and 1 Top-Hat valve),
and 7 received 25 mm valves (2 St. Jude Medical valves, 3
Carpentier-Edwards bioprostheses, 1 TEKNA valve, and Car-
bomedics valve). One patient each received a 27 mm valve
and a 29 mm valve. Combined operations were coronary ar-
tery bypass surgery (n=8), ascending aorta wrapping or rep-
lacement (n=7), Maze operation (n=1), and patent foramen
ovale closure (n=1). Mean cardiopulmonary bypass (CPB)
time and aorta cross-clamping (ACC) time were 135.6±
56.6 min and 85.6±35.1 min, respectively. 
In-hospital mortality occurred in one patient (1/41, 2.4%)
who was a 65-yr-old male diagnosed with aortic stenosis and
infective endocarditis, and who had an LV EF of 19% and an
aortic valve area of 0.43 cm2. While that patient underwent
aortic valve replacement with a Carpentier-Edwards pericar-
dial valve, sepsis caused by infective endocarditis was not tr-
eated, and the patient ultimately died. Post-operative com-
plications occurred in 7 patients, such as permanent pacemak-
er insertion due to complete atrioventricular block (n=1),
mediastinitis (n=1), post-operative bleeding (n=2), frequent
ventricular fibrillation (n=1), acute renal failure (n=1), wound
infection (n=2), and infective endocarditis (n=1).
Echocardiograms performed immediate post-operation
showed improvement in LV EF, LV mass, LV diameter, and
LV volume compared to pre-operative findings (Table 2). Dur-
ing the follow-up period, LV ejection fraction, LV diameter,
and LV mass improved dramatically up to 6 months post-op-
eratively, at which point they remained stable (Fig. 2).
Functional recovery of >10% in the left ventricle was ob-
served in 15 patients (Table 3). Those patients differed from
patients with <10% left ventricular recovery in terms of aor-
tic valve area (P<0.026) and left ventricular systolic posterior
wall thickness (P<0.021). Pre-operative LV mass was greater
in patients who recovered more effectively. 
Late death occurred in 12 patients. Of those, 11 patients
died due to cardiac-related problems (late death due to un-
Fig. 2. Post-operative changes in echocardiographic findings; (A) left ventricular ejection fraction (LV EF), (B) Left ventricular mass, (C) Dias-
tolic left ventricular internal dimension (LVIDd), (D) Systolic left ventricular internal dimension (LVIDs), (E) left ventricular end-systolic vol-
ume (ESV), and (F) left ventricular end-diastolic volume (EDV).
*P=0.437; 
� P=0.822; 
� P=0.645; 
�P=0.856; 
‖P=0.044; 
¶P=0.597; 
� � P=0.4; 
� � P=0.725.
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known etiology was regarded as a cardiac death). Analysis of
risk factors for cardiac-related death were performed on patient
demographics (age, sex, diabetes mellitus, systemic hyperten-
sion, chronic renal failure, and so on), preoperative cardiac
function, LV dimension or wall thickness, presence of atrial
fibrillation or pulmonary hypertension, NYHA functional
class III or IV, emergency operation, combined coronary artery
disease, and operative variables (CPB time and ACC time).
Univariate analysis showed pre-operative atrial fibrillation
(P=0.041) to be a risk factor for cardiac related death. Mul-
tivariate analysis showed pre-operative atrial fibrillation,
NYHA FC IV, and LV systolic posterior wall thickness to be
significant risk factors for cardiac-related death (Table 4).
Overall survival rates at 1 yr, 5 yr, and 10 yr were 85.4±5.5
%, 72.9±7.5%, and 51.6±12.0%, respectively.
DISCUSSION
Aortic stenosis may be caused by degenerative calcification,
congenital malformation, or rheumatic fever. Severe aortic
stenosis is defined as an aortic valve area less than 1.0 cm2 (4).
Patients with aortic stenosis and left ventricular dysfunction
usually improve after surgical treatment of afterload mismatch
(5, 6). However, patients sometimes present with severe aor-
tic stenosis and severe left ventricular dysfunction, which leads
to concerns over the post-operative state and long-term out-
comes.
Advanced patient age, poor preoperative LV function,
*Paired t-test.
Values represent mean±SD.
LV, left ventricle; EF, ejection fraction; LVMI, left ventricle mass index;
LVIDs, systolic left ventricular internal diameter; LVIDd, diastolic left
ventricular internal diameter; LVPWs, left ventricle systolic posterior
wall thickness; LVPWd, left ventricle diastolic posterior wall thickness;
IVSs, systolic interventricular septum; IVSd, diastolic interventricular
septum; ESV, end-systolic volume; EDV, end-diastolic volume.
Pre-operation
Immediate 
P value*
post-operation
LV EF (%) 27.2±5.5 37.4±11.3 <0.001
LVMI (g/m
2) 244.2±75.3 217.5±71.6 0.006
LVIDs (mm) 51.1±9.0 43.4±10.4 <0.001
LVIDd (mm) 62.5±9.3 55.8±9.6 <0.001
LVPWs (mm) 15.7±3.1 17.4±2.8 <0.001
LVPWd (mm) 12.3±1.9 13.0±2.3 0.019
IVSs thickness (mm) 12.9±2.1 13.2±2.5 0.344
IVSd thickness (mm) 12.6±2.0 13.0±2.5 0.194
ESV (mL) 130.3±58.8 88.5±45.2 <0.001
EDV (mL) 176.2±68.7 136.3±56.5 <0.001
Table 2. Changes between pre-operative and immediate post-
operative echocardiographic findings
Values represent mean±SD.
Values in parentheses are percentages.
LV, left ventricle; EF, ejection fraction; PG, pressure gradient; BSA,
body surface area; LVPWs, left ventricle systolic posterior wall thickness;
LVPWd, left ventricle diastolic posterior wall thickness; LVIDs, systolic
left ventricular internal diameter; LVIDd, diastolic left ventricular internal
diameter; ESV, end-systolic volume; EDV, end-diastolic volume.
△EF <10% △EF ≥10%
P value
(n=25) (n=15)
LV EF (%) 27.3±5.9 26.4±6.5 0.665
Aortic valve area (cm
2) 0.6±0.19 0.45±0.21 0.026
PG mean (mmHg) 45.1±18.2 53.1±15.3 0.166
BSA (m
2) 1.68±0.2 1.59±0.2 0.207
Coronary artery disease 7 (28) 3 (20) 0.715
Atrial fibrillation 6 (24) 4 (26.7) 1.0
Valve size (mm) 22.4±2.0 22.6±2.6 0.828
LV mass index 226.3±57.4 279.4±89.9 0.061
LVPWs 14.9±3.1 17.2±2.4 0.021
LVPWd 12.0±1.8 13.1±1.9 0.093
LVIDs 51.2±7.3 50.5±11.2 0.803
LVIDd 62.3±7.6 61.9±11.5 0.906
ESV index 74.2±22.6 87.9±42.6 0.288
EDV index 100.9±26.3 116.9±48.9 0.270
Table 3. Comparison of pre-operative parameters in patients
with or without >10% functional recovery immediately postop-
eratively
*Cox proportional hazard model (backward LR).
HR, hazard ratio; CI, confidence Interval; NYHA FC, New York Heart Association Functional class; LVPWs, left ventricle systolic posterior wall thick-
ness; LVPWd, left ventricle diastolic posterior wall thickness; IVSs, systolic interventricular septum; IVSd, diastolic interventricular septum; LVMI, left
ventricular mass index.
Univariate analysis Multivariate analysis
HR CI P value HR CI P value
Atrial fibrillation 3.40 1.052-11.001 0.041 5.079 1.212-21.281 0.026
Coronary artery disease 3.06 0.982-9.542 0.054 ---
NYHA FC IV 1.978 0.593-6.592 0.267 6.251 1.438-27.174 0.015
LVPWs 1.249 0.996-1.566 0.054 1.26 1.023-1.551 0.029
LVPWd 1.352 0.979-1.868 0.067 ---
IVSs 1.297 0.989-1.702 0.06 ---
IVSd 1.306 0.99-1.723 0.059 ---
LVMI 1.005 0.998-1.012 0.138 ---
Table 4. Risk factors for postoperative cardiac-related death
Findings
Factors
Parameters816 S.-H. Jung, J.W. Lee, H.G. Je, et al.
NYHA class IV symptoms, concomitant coronary artery dis-
ease, severe pre-operative renal dysfunction, active endocardi-
tis, female gender, emergency or salvage operation, and pre-
vious aortic valve replacement have been associated with in-
creased surgical mortality in several series (5-7). LV dysfunc-
tion is an uncommon consequence of aortic stenosis (about
5% of patients), and atrial fibrillation also occurs in only 5%
of patients with aortic stenosis (8). In the present study, 10
patients (24.3%) showed atrial fibrillation, indicating that
patients with severe LV dysfunction tend to have atrial fib-
rillation more frequently. The hospital mortality rate in such
patients is reported as 8-10.9% (6, 7, 9). In the present study,
the in-hospital mortality rate was 2.4% (1/41), and this is an
acceptable result compared with other reports. The estimat-
ed five year survival of the population after AVR was 72.9%
and similar to other reports (6).
Collinson et al. reported that there was a more rapid im-
provement in LV function following aortic valve replacement
with a stentless prosthesis in patients with poor left ventric-
ular dysfunction (10, 11). Improvements in those receiving
stented valves appeared delayed, although there were no dif-
ferences between the groups in terms of LV function or mass
at follow-up. Conversely, others reported that they were not
able to detect significant differences between stentless and
stented valve groups in terms of hemodynamic performance
and regression of left ventricular mass (12, 13). In the present
study stented prosthetic valves were only used. The present
study found a significant improvement in LV EF, LV mass,
and LV dimension after the immediate post-operative echocar-
diogram, which was usually performed at 1 week post-oper-
atively. It was reported that LV mass and functional recovery
was complete at 1 or 1.5 yr, and that pre-operative LV func-
tion was related to normalization of the LV mass index (14-
17). Despite the present study involving patients with severe
LV dysfunction, LV function improved dramatically, with
most of this improvement occurring in the first 6 months
post-operatively. 
Functional recovery of >10% in the left ventricle was ob-
served in 15 patients (Table 3). Those patients differed from
patients with <10% left ventricular recovery in terms of aor-
tic valve area (P<0.026). Therefore, it could be said that pa-
tients with a smaller aortic valve area appeared to have a gre-
ater chance of functional recovery after reduction of afterload
(18).
Multivariate analysis showed pre-operative atrial fibrilla-
tion and NYHA FC IV to be significant risk factors for car-
diac-related death. In the present study, the maze operation
was done in only one patient (among ten patients with atri-
al fibrillation), so the further study would be necessary to
assess the impact of maze operation in these patients for the
survival. 
It is generally desirable to avoid using of 19 mm prosthet-
ic valves due to the risk of patient-prosthesis mismatch. The
19 mm valve was used in 5 patients, none of whom experi-
enced cardiac-related death during the follow-up period. This
finding is consistent with those of others showing that valve
type or size was not related to normalization of LV mass index
(19).
This study had several limitations, most of them being
inherent to the retrospective analysis of a single center. First-
ly, the sample size was relatively small because severe aortic
stenosis and severe LV dysfunction are rarely concomitant.
Secondly, our choice of a 35% in LV EF as a cut off value of
severe LV dysfunction may seem arbitrary. This choice was
based on the practically used criteria in our institute. Third-
ly, echocardiographic follow-up at more than 6 months was
possible in only 31 of 41 patients, while immediate post-oper-
ative echocardiography was possible in 40 patients.
In conclusion, the present study found that operative mor-
tality in patients with significant aortic stenosis and severe
LV dysfunction was acceptable. Changes in LV function, LV
mass, LV volume, and dimension were highly predictable. LV
mass regression, functional recovery, and ventricular volume
improvements were progressive processes that occurred soon
after surgery and were mostly completed at 6 months. Pre-
operative predictors for cardiac-related death were pre-oper-
ative atrial fibrillation and NYHA FC IV according to the
multivariate analysis. The data indicate that aortic valve re-
placement should be considered more positively even though
patients had significant aortic stenosis combined with severe
LV dysfunction. Further study would be necessary to assess
the impact of maze operation in patients with the significant
AS with severe LV dysfunction combined atrial fibrillation.
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